mRNA is an endogenous ligand for toll-like receptor 3

Mfold web server for nucleic acid folding and hybridization prediction

Zuker, M. (2003) · Nucleic Acids Research · doi:10.1093/nar/gkg595 · Cited by 13,404 · see citing works

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129 · see citing works

Tolerance, Danger, and the Extended Family

Matzinger, P. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.005015 · Cited by 4,848 · see citing works

Optimal computer folding of large RNA sequences using thermodynamics and auxiliary information

Zuker, M., & Stiegler, P. (1981) · Nucleic Acids Research · doi:10.1093/nar/9.1.133 · Cited by 3,604 · see citing works

Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging

Mori, S., Crain, B. J., Chacko, V. P., & van Zijl, P. C. M. (1999) · Annals of Neurology · doi:10.1002/1531-8249(199902)45:2 · Cited by 3,479 · see citing works

Subsets of Human Dendritic Cell Precursors Express Different Toll-like Receptors and Respond to Different Microbial Antigens

Kadowaki, N., Ho, S., Antonenko, S., de Waal Malefyt, R., Kastelein, R. A., Bazan, F., & Liu, Y.-J. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.863 · Cited by 1,964 · see citing works

Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors

Leadbetter, E. A., Rifkin, I. R., Hohlbaum, A. M., Beaudette-Zlatanova, B. C., Shlomchik, M. J., & Marshak‐Rothstein, A. (2002) · Nature · doi:10.1038/416603a · Cited by 1,899 · see citing works

IRF Family of Transcription Factors as Regulators of Host Defense

Taniguchi, T., Ogasawara, K., Takaoka, A., & Tanaka, N. (2001) · Annual Review of Immunology · doi:10.1146/annurev.immunol.19.1.623 · Cited by 1,658 · see citing works

Oligosaccharides of Hyaluronan Activate Dendritic Cells via Toll-like Receptor 4

Termeer, C., Benedix, F., Sleeman, J., Fieber, C., Voith, U., Ahrens, T., Miyake, K., Freudenberg, M., Galanos, C., & Simon, J. C. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20001858 · Cited by 1,378 · see citing works

Cd8+ but Not Cd8− Dendritic Cells Cross-Prime Cytotoxic T Cells in Vivo

den Haan, J. M. M., Lehar, S. M., & Bevan, M. J. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.12.1685 · Cited by 1,319 · see citing works

Necrotic but not apoptotic cell death releases heat shock proteins, which deliver a partial maturation signal to dendritic cells and activate the NF-κB pathway

Basu, S., Binder, R. J., Suto, R., Anderson, K. M., & Srivastava, P. K. (2000) · International Immunology · doi:10.1093/intimm/12.11.1539 · Cited by 1,305 · see citing works

IRAK-M Is a Negative Regulator of Toll-like Receptor Signaling

Kobayashi, K. S., Hernandez, L. D., Galán, J. E., Janeway, C. A., Medzhitov, R. M., & Flavell, R. A. (2002) · Cell · doi:10.1016/s0092-8674(02)00827-9 · Cited by 1,289 · see citing works

Cutting Edge: A Novel Toll/IL-1 Receptor Domain-Containing Adapter That Preferentially Activates the IFN-β Promoter in the Toll-Like Receptor Signaling

Yamamoto, M., Sato, S., Mori, K., Hoshino, K., Takeuchi, O., Takeda, K., & Akira, S. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.12.6668 · Cited by 1,227 · see citing works

TICAM-1, an adaptor molecule that participates in Toll-like receptor 3–mediated interferon-β induction

Oshiumi, H., Matsumoto, M., Funami, K., Akazawa, T., & Seya, T. (2003) · Nature Immunology · doi:10.1038/ni886 · Cited by 1,208 · see citing works

Pattern Recognition Receptors

Gordon, S. (2002) · Cell · doi:10.1016/s0092-8674(02)01201-1 · Cited by 1,153 · see citing works

Differential Expression and Regulation of Toll-Like Receptors (TLR) in Human Leukocytes: Selective Expression of TLR3 in Dendritic Cells

Muzio, M., Bosisio, D., Polentarutti, N., D’Amico, G., Stoppacciaro, A., Mancinelli, R., Veer, C. V. ′., Pentón‐Rol, G., Ruco, L., Allavena, P., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.11.5998 · Cited by 1,058 · see citing works

TIRAP: an adapter molecule in the Toll signaling pathway

Horng, T., Barton, G. M., & Medzhitov, R. M. (2001) · Nature Immunology · doi:10.1038/ni0901-835 · Cited by 970 · see citing works

Fibrinogen Stimulates Macrophage Chemokine Secretion Through Toll-Like Receptor 4

Smiley, S. T., King, J. A., & Hancock, W. W. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.5.2887 · Cited by 946 · see citing works

Toll-Like Receptor 4-Dependent Activation of Dendritic Cells by β-Defensin 2

Biragyn, A., Ruffini, P. A., Leifer, C. A., Klyushnenkova, E., Shakhov, A., Chertov, O., Shirakawa, A., Farber, J. M., Segal, D. M., Oppenheim, J. J., et al. (2002) · Science · doi:10.1126/science.1075565 · Cited by 904 · see citing works

TLR4, but not TLR2, mediates IFN-β–induced STAT1α/β-dependent gene expression in macrophages

Toshchakov, V. Y., Jones, B. W., Perera, P., Thomas, K., Cody, M. J., Zhang, S., Williams, B. R. G., Major, J. A., Hamilton, T. A., Fenton, M. J., et al. (2002) · Nature Immunology · doi:10.1038/ni774 · Cited by 803 · see citing works

Targeted disruption of IRF-1 or IRF-2 results in abnormal type I IFN gene induction and aberrant lymphocyte development

Matsuyama, T., Kimura, T., Kitagawa, M., Pfeffer, K., Kawakami, T., Watanabe, N., Kündig, T. M., Amakawa, R., Kishihara, K., Wakeham, A., et al. (1993) · Cell · doi:10.1016/s0092-8674(05)80086-8 · Cited by 649 · see citing works

Receptor-Mediated Monitoring of Tissue Well-Being Via Detection of Soluble Heparan Sulfate by Toll-Like Receptor 4

Johnson, G. B., Brunn, G. J., Kodaira, Y., & Platt, J. L. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.10.5233 · Cited by 648 · see citing works

Regulation of Toll-Like Receptors in Human Monocytes and Dendritic Cells

Visintin, A., Mazzoni, A., Spitzer, J. H., Wyllie, D. H., Dower, S., & Segal, D. M. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.1.249 · Cited by 611 · see citing works

Mutation of DNASE1 in people with systemic lupus erythematosus

Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., & Kuroda, Y. (2001) · Nature Genetics · doi:10.1038/91070 · Cited by 598 · see citing works

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Heiser, A., Coleman, D., Dannull, J., Yancey, D., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0214364 · Cited by 562 · see citing works

Endogenous ligands of Toll-like receptors: implications for regulating inflammatory and immune responses

Beg, A. A. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(02)02317-7 · Cited by 495 · see citing works

Autologous dendritic cells transfected with prostate-specific antigen RNA stimulate CTL responses against metastatic prostate tumors

Heiser, A., Coleman, D., Dannull, J., Yancey, D. R., Maurice, M. A., Lallas, C. D., Dahm, P., Niedzwiecki, D., Gilboa, E., & Vieweg, J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci14364 · Cited by 487 · see citing works

Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling

Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K., & Seya, T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00380-7 · Cited by 451 · see citing works

TOLL-like receptors linking innate and adaptive immune response

Werling, D., & Jungi, T. W. (2002) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(02)00228-3 · Cited by 403 · see citing works

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA

Nair, S. K., Boczkowski, D., Morse, M., Cumming, R. I., Lyerly, H. K., & Gilboa, E. (1998) · Nature Biotechnology · doi:10.1038/nbt0498-364 · Cited by 398 · see citing works

An Innate Sense of Danger

Matzinger, P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb03118.x · Cited by 360 · see citing works

Induction of cytotoxic T cell responses and tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells.

Nair, S. K., Heiser, A., Boczkowski, D., Majumdar, A. S., Naoe, M., LEBKOWSKI, J. S., Vieweg, J., & Gilboa, E. (2000) · Nature Medicine · doi:10.1038/79519 · Cited by 348 · see citing works

The dsRNA binding protein family: critical roles, diverse cellular functions

Saunders, L. R., & Barber, G. N. (2003) · The FASEB Journal · doi:10.1096/fj.02-0958rev · Cited by 338 · see citing works

Toll-Like Receptors and Their Ligands

Barton, G. M., & Medzhitov, R. M. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59430-4_5 · Cited by 302 · see citing works

Multiple Control Elements Mediate Activation of the Murine and Human Interleukin 12 p40 Promoters: Evidence of Functional Synergy between C/EBP and Rel Proteins

Plevy, S. E., Gemberling, J. H. M., Hsu, S., Dorner, A. J., & Smale, S. T. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.8.4572 · Cited by 302 · see citing works

A Subset of Toll-Like Receptor Ligands Induces Cross-presentation by Bone Marrow-Derived Dendritic Cells

Datta, S. K., Redecke, V., Prilliman, K. R., Takabayashi, K., Corr, M., Tallant, T. C., DiDonato, J. A., Dziarski, R., Akira, S., Schoenberger, S. P., et al. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.8.4102 · Cited by 300 · see citing works

Cutting Edge: The Immunostimulatory Activity of the Lung Surfactant Protein-A Involves Toll-Like Receptor 4

Guillot, L., Balloy, V., McCormack, F. X., Golenbock, D. T., Chignard, M., & Si‐Tahar, M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.12.5989 · Cited by 299 · see citing works

Eosinophils, eosinophil ribonucleases, and their role in host defense against respiratory virus pathogens

Rosenberg, H. F., & Domachowske, J. B. (2001) · Journal of Leukocyte Biology · doi:10.1189/jlb.70.5.691 · Cited by 287 · see citing works

IFNs activate toll-like receptor gene expression in viral infections

Miettinen, M., Sareneva, T., Julkunen, I., & Matikainen, S. (2001) · Genes and Immunity · doi:10.1038/sj.gene.6363791 · Cited by 282 · see citing works

Heat Shock Proteins as Ligands of Toll-Like Receptors

Vabulas, R. M., Wagner, H., & Schild, H. (2002) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59430-4_11 · Cited by 276 · see citing works

Cellular Events Mediated by Lipopolysaccharide-stimulated Toll-like Receptor 4

Yang, H., Young, D. W., Gusovsky, F., & Chow, J. C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m002896200 · Cited by 269 · see citing works

Review: Activities of IRF-1

Kröger, A., Köster, M., Schroeder, K., Häuser, H., & Mueller, P. P. (2002) · Journal of Interferon & Cytokine Research · doi:10.1089/107999002753452610 · Cited by 265 · see citing works

TLR2: cellular sensor for microbial and endogenous molecular patterns.

Kirschning, C., & Schumann, R. (2002) · Current Topics in Microbiology and Immunology · doi:10.1007/978-3-642-59430-4_8 · Cited by 232 · see citing works

Induction of Tumor-Specific Cytotoxic T Lymphocytes in Cancer Patients by Autologous Tumor RNA-Transfected Dendritic Cells

Nair, S. K., Morse, M. A., Boczkowski, D., Cumming, R. I., Vasović, L. V., Gilboa, E., & Lyerly, H. K. (2002) · Annals of Surgery · doi:10.1097/00000658-200204000-00013 · Cited by 205 · see citing works

Induction of Polyclonal Prostate Cancer-Specific CTL Using Dendritic Cells Transfected with Amplified Tumor RNA

Heiser, A., Maurice, M. A., Yancey, D. R., Wu, N., Dahm, P., Pruitt, S. K., Boczkowski, D., Nair, S. K., Ballo, M. S., Gilboa, E., et al. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.5.2953 · Cited by 198 · see citing works

Pellino 1 Is Required for Interleukin-1 (IL-1)-mediated Signaling through Its Interaction with the IL-1 Receptor-associated Kinase 4 (IRAK4)-IRAK-Tumor Necrosis Factor Receptor-associated Factor 6 (TRAF6) Complex*

Jiang, Z.-F., Johnson, H., Nie, H., Qin, J.-Z., Bird, T., & Li, X.-X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212112200 · Cited by 186 · see citing works

HIV Gag mRNA Transfection of Dendritic Cells (DC) Delivers Encoded Antigen to MHC Class I and II Molecules, Causes DC Maturation, and Induces a Potent Human In Vitro Primary Immune Response

Weissman, D., Ni, H., Scales, D. A., Dude, A., Capodici, J., McGibney, K., Abdool, A. J., Isaacs, S. N., Cannon, G., & Karikó, K. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.8.4710 · Cited by 178 · see citing works

Toll-Like Receptor 3 Mediates a More Potent Antiviral Response Than Toll-Like Receptor 4

Doyle, S. E., O’Connell, R. M., Vaidya, S. A., Chow, E. K., Yee, K. T., & Cheng, G. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3565 · Cited by 177 · see citing works

Nucleosome remodeling at the IL-12 p40 promoter is a TLR-dependent, Rel-independent event

Weinmann, A. S., Mitchell, D. M., Sanjabi, S., Bradley, M. N., Hoffmann, A., Liou, H.-C., & Smale, S. T. (2001) · Nature Immunology · doi:10.1038/83168 · Cited by 161 · see citing works

The interferon system and interferon regulatory factor transcription factors – studies from gene knockout mice

Sato, M., Taniguchi, T., & Tanaka, N. (2001) · Cytokine & Growth Factor Reviews · doi:10.1016/s1359-6101(00)00032-0 · Cited by 161 · see citing works

RNA sequestration to pathological lesions of neurodegenerative diseases

Ginsberg, S. D., Galvin, J. E., Chiu, T.-L. S., Lee, V. M. ‐., Masliah, E., & Trojanowski, J. Q. (1998) · Acta Neuropathologica · doi:10.1007/s004010050923 · Cited by 142 · see citing works

Double-stranded RNA Signaling by Toll-like Receptor 3 Requires Specific Tyrosine Residues in Its Cytoplasmic Domain

Sarkar, S. N., Smith, H., Rowe, T. M., & Sen, G. C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200655200 · Cited by 117 · see citing works

Cross-Presentation of Antigens by Dendritic Cells

Heath, W. R., Carbone, F., & Belz, G. T. (2002) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v22.i5-6.50 · Cited by 70 · see citing works

Structure-function correlates of autoantibodies to nucleic acids. Lessons from immunochemical, genetic and structural studies

Eilat, D., & Anderson, W. F. (1994) · Molecular Immunology · doi:10.1016/0161-5890(94)90154-6 · Cited by 61 · see citing works

Extracellular mRNA Induces Dendritic Cell Activation by Stimulating Tumor Necrosis Factor-α Secretion and Signaling through a Nucleotide Receptor

Ni, H., Capodici, J., Cannon, G., Communi, D., Boeynaems, J., Karikó, K., & Weissman, D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110729200 · Cited by 60 · see citing works

Phosphate-enhanced transfection of cationic lipid-complexed mRNA and plasmid DNA

Karikó, K., Kuo, A., Barnathan, E. S., & Langer, D. J. (1998) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/s0005-2736(97)00238-1 · Cited by 48 · see citing works

Involvement of TIRAP/MAL in signaling for the activation of interferon regulatory factor 3 by lipopolysaccharide

Shinobu, N., Iwamura, T., Yoneyama, M., Yamaguchi, K., Suhara, W., Fukuhara, Y., Amano, F., & Fujita, T. (2002) · FEBS Letters · doi:10.1016/s0014-5793(02)02636-4 · Cited by 48 · see citing works

βAPP and Furin mRNA Concentrates in Immature Senile Plaques in the Brain of Alzheimer Patients

Marcinkiewicz, M. M. (2002) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/61.9.915 · Cited by 37 · see citing works

Cross-Presentation of Cell-Associated Antigens by Dendritic Cells

Larsson, M., Fonteneau, J., & Bhardwaj, N. (2003) · Current topics in microbiology and immunology · doi:10.1007/978-3-662-06508-2_12 · Cited by 34 · see citing works

Characterization of Transiently and Constitutively Expressed Progesterone Receptors: Evidence for Two Functional States

Smith, C. L., Wolford, R. G., O’Neill, T. B., & Hager, G. L. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.7.0482 · Cited by 25 · see citing works

Phenotypic analysis of the murine CD4-related glycoprotein, CD223 (LAG-3)

(2002) · doi:10.1002/1521-4141(200208)32:8

Untitled work

Kalina (2002) · doi:10.1002/1521-4141(200209)32:9

Immunogenic cell death and DAMPs in cancer therapy

Krysko, D. V., Garg, A. D., Kaczmarek, A., Krysko, O., Agostinis, P., & Vandenabeele, P. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3380 · Cited by 3,223 · see citing works

Sterile inflammation: sensing and reacting to damage

Chen, G. Y., & Nuñez, G. (2010) · Nature Reviews Immunology · doi:10.1038/nri2873 · Cited by 3,051 · see citing works

Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA

Karikó, K., Buckstein, M., Ni, H., & Weissman, D. (2005) · Immunity · doi:10.1016/j.immuni.2005.06.008 · Cited by 2,728 · see citing works

Incorporation of Pseudouridine Into mRNA Yields Superior Nonimmunogenic Vector With Increased Translational Capacity and Biological Stability

Karikó, K., Muramatsu, H., Welsh, F. A., Ludwig, J., Kato, H., Akira, S., & Weissman, D. (2008) · Molecular Therapy · doi:10.1038/mt.2008.200 · Cited by 1,930 · see citing works

Astrocytes are active players in cerebral innate immunity

Farina, C., Aloisi, F., & Meinl, E. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.01.005 · Cited by 1,304 · see citing works

Mechanisms of Age-Related Macular Degeneration

Ambati, J., & Fowler, B. J. (2012) · Neuron · doi:10.1016/j.neuron.2012.06.018 · Cited by 1,029 · see citing works

Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens

Jongbloed, S. L., Kassianos, A. J., McDonald, K. J., Clark, G. J., Ju, X., Angel, C. E., Chen, C. J., Dunbar, P. R., Wadley, R. B., Jeet, V., et al. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20092140 · Cited by 1,019 · see citing works

DAMPening Inflammation by Modulating TLR Signalling

Piccinini, A. M., & Midwood, K. S. (2010) · Mediators of Inflammation · doi:10.1155/2010/672395 · Cited by 974 · see citing works

Nucleic acids of mammalian origin can act as endogenous ligands for Toll-like receptors and may promote systemic lupus erythematosus

Barrat, F. J., Meeker, T., Gregorio, J. D., Chan, J. H., Uematsu, S., Akira, S., Chang, B., Duramad, O., & Coffman, R. L. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050914 · Cited by 932 · see citing works

Modified mRNA vaccines protect against zika virus infection

Richner, J. M., Himansu, S., Dowd, K. A., Butler, S. L., Salazar, V., Fox, J. M., Julander, J. G., Tang, W. W., Shresta, S., Pierson, T. C., et al. (2017) · Cell · doi:10.1016/j.cell.2017.02.017 · Cited by 909 · see citing works

Wallerian degeneration: gaining perspective on inflammatory events after peripheral nerve injury

Gaudet, A. D., Popovich, P. G., & Ramer, M. S. (2011) · Journal of Neuroinflammation · doi:10.1186/1742-2094-8-110 · Cited by 903 · see citing works

Extracellular histones promote thrombin generation through platelet-dependent mechanisms: involvement of platelet TLR2 and TLR4

Semeraro, F., Ammollo, C. T., Morrissey, J. H., Dale, G. L., Friese, P., Esmon, N. L., & Esmon, C. T. (2011) · Blood · doi:10.1182/blood-2011-03-343061 · Cited by 870 · see citing works

The role of oxidative stress during inflammatory processes

Lugrin, J., Rosenblatt‐Velin, N., Parapanov, R., & Liaudet, L. (2013) · Biological Chemistry · doi:10.1515/hsz-2013-0241 · Cited by 742 · see citing works

TLR signaling tailors innate immune responses in human microglia and astrocytes

Jack, C. S., Arbour, N., Manusow, J., Montgrain, V., Blain, M., McCrea, E., Shapiro, A., & Antel, J. P. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.7.4320 · Cited by 734 · see citing works

The immunology of acute stroke

Chamorro, Á., Meisel, A., Planas, A. M., Urra, X., van de Beek, D., & Veltkamp, R. C. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.98 · Cited by 707 · see citing works

Necrosis, a well-orchestrated form of cell demise: Signalling cascades, important mediators and concomitant immune response

Festjens, N., Vanden Berghe, T., & Vandenabeele, P. (2006) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2006.06.014 · Cited by 710 · see citing works

Endogenous ligands of Toll-like receptors

Tsan, M., & Gao, B. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304127 · Cited by 683 · see citing works

Immune activation in brain aging and neurodegeneration: too much or too little?

Lucin, K. M., & Wyss-Coray, T. (2009) · Neuron · doi:10.1016/j.neuron.2009.08.039 · Cited by 679 · see citing works

Advances in mRNA Vaccines for Infectious Diseases

Zhang, C., Maruggi, G., Shan, H., & Li, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00594 · Cited by 680 · see citing works

Preclinical and clinical demonstration of immunogenicity by mRNA vaccines against H10N8 and H7N9 influenza viruses

Bahl, K., Senn, J. J., Yuzhakov, O., Bulychev, A., Brito, L. A., Hassett, K. J., Laska, M. E., Smith, M., Almarsson, Ö., Thompson, J., et al. (2017) · Molecular Therapy · doi:10.1016/j.ymthe.2017.03.035 · Cited by 642 · see citing works

Developing mRNA-vaccine technologies

Schlake, T., Thess, A., Fotin-Mleczek, M., & Kallen, K.-J. (2012) · RNA Biology · doi:10.4161/rna.22269 · Cited by 622 · see citing works

Pathogenic mechanisms following ischemic stroke

Khoshnam, S. E., Winlow, W., Farzaneh, M., Farbood, Y., & Moghaddam, H. F. (2017) · Neurological Sciences · doi:10.1007/s10072-017-2938-1 · Cited by 618 · see citing works

Macrophage activation by endogenous danger signals

Zhang, X., & Mosser, D. (2007) · The Journal of Pathology · doi:10.1002/path.2284 · Cited by 612 · see citing works

Crystal Structure of Human Toll-Like Receptor 3 (TLR3) Ectodomain

Choe, J., Kelker, M. S., & Wilson, I. A. (2005) · Science · doi:10.1126/science.1115253 · Cited by 603 · see citing works

The tangled history of mRNA vaccines

Dolgin, E. (2021) · Nature · doi:10.1038/d41586-021-02483-w · Cited by 556 · see citing works

Endogenous toll‐like receptor ligands and their biological significance

Yu, L., Wang, L., & Chen, S. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01127.x · Cited by 531 · see citing works

Toll-like Receptor 9–Dependent and –Independent Dendritic Cell Activation by Chromatin–Immunoglobulin G Complexes

Uccellini, M. B., Broughton, C., Mackay, F., Akira, S., Marshak‐Rothstein, A., & Rifkin, I. R. (2004) · The Journal of Experimental Medicine · doi:10.1084/jem.20031942 · Cited by 519 · see citing works

Toll-like receptor 9 controls anti-DNA autoantibody production in murine lupus

Christensen, S. R., Kashgarian, M. J., Alexopoulou, L., Flavell, R. A., Akira, S., & Shlomchik, M. J. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050338 · Cited by 516 · see citing works

Self-assembled mRNA vaccines

Kim, J., Eygeris, Y., Gupta, M., & Sahay, G. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.12.014 · Cited by 514 · see citing works

Inflammation and fibrosis

Mack, M. (2017) · Matrix Biology · doi:10.1016/j.matbio.2017.11.010 · Cited by 516 · see citing works

Toll-like receptor signaling in neural plasticity and disease

Okun, E., Griffioen, K. J. S., & Mattson, M. P. (2011) · Trends in Neurosciences · doi:10.1016/j.tins.2011.02.005 · Cited by 513 · see citing works

The dawn of mRNA vaccines: the COVID-19 case

Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2021) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.03.043 · Cited by 504 · see citing works

The Pathogenesis of Lupus Nephritis

Lech, M., & Anders, H. (2013) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013010026 · Cited by 502 · see citing works

Immunogenic cell death, DAMPs and anticancer therapeutics: An emerging amalgamation

Garg, A. D., Nowis, D., Gołąb, J., Vandenabeele, P., Krysko, D. V., & Agostinis, P. (2009) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2009.08.003 · Cited by 498 · see citing works

Molecular characteristics of immunogenic cancer cell death

Tesnière, A., Panaretakis, T., Kepp, O., Apétoh, L., Ghiringhelli, F., Zitvogel, L., & Kroemer, G. (2007) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4402269 · Cited by 492 · see citing works

Toll-like receptors in health and disease in the brain: mechanisms and therapeutic potential

Hanke, M. L., & Kielian, T. (2011) · Clinical Science · doi:10.1042/cs20110164 · Cited by 493 · see citing works

Pattern recognition receptors and central nervous system repair

Kigerl, K. A., de Rivero Vaccari, J. P., Dietrich, W. D., Popovich, P. G., & Keane, R. W. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.01.001 · Cited by 490 · see citing works

Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines

Nance, K. D., & Meier, J. L. (2021) · ACS Central Science · doi:10.1021/acscentsci.1c00197 · Cited by 466 · see citing works

Immunogenicity of lipid nanoparticles and its impact on the efficacy of mRNA vaccines and therapeutics

Lee, Y., Jeong, M., Park, J., Jung, H., & Lee, H. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01086-x · Cited by 477 · see citing works

Small Interfering RNAs Mediate Sequence-Independent Gene Suppression and Induce Immune Activation by Signaling through Toll-Like Receptor 3

Karikó, K., Bhuyan, P. K., Capodici, J., & Weissman, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.11.6545 · Cited by 446 · see citing works

TLR3 is an endogenous sensor of tissue necrosis during acute inflammatory events

Cavassani, K. A., Ishii, M., Wen, H., Schaller, M. A., Lincoln, P., Lukacs, N. W., Hogaboam, C. M., & Kunkel, S. L. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081370 · Cited by 447 · see citing works

Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses

Garg, A. D., & Agostinis, P. (2017) · Immunological Reviews · doi:10.1111/imr.12574 · Cited by 448 · see citing works

RIG-I and Other RNA Sensors in Antiviral Immunity

Chow, K. T., Gale, M., & Loo, Y. (2018) · Annual Review of Immunology · doi:10.1146/annurev-immunol-042617-053309 · Cited by 429 · see citing works

Induction of Inflammatory Cytokines and Interferon Responses by Double-stranded and Single-stranded siRNAs is Sequence-dependent and Requires Endosomal Localization

Sioud, M. (2005) · Journal of Molecular Biology · doi:10.1016/j.jmb.2005.03.013 · Cited by 415 · see citing works

Dendrimer-RNA nanoparticles generate protective immunity against lethal Ebola, H1N1 influenza, and <i>Toxoplasma gondii</i> challenges with a single dose

Chahal, J. S., Khan, O. F., Cooper, C. L., McPartlan, J. S., Tsosie, J. K., Tilley, L. D., Sidik, S. M., Lourido, S., Langer, R., Bavari, S., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1600299113 · Cited by 414 · see citing works

Many stimuli pull the necrotic trigger, an overview

Vanlangenakker, N., Berghe, T. V., & Vandenabeele, P. (2011) · Cell Death and Differentiation · doi:10.1038/cdd.2011.164 · Cited by 407 · see citing works

Toll‐like receptors, endogenous ligands, and systemic autoimmune disease

Rifkin, I. R., Leadbetter, E. A., Busconi, L., Viglianti, G. A., & Marshak‐Rothstein, A. (2005) · Immunological Reviews · doi:10.1111/j.0105-2896.2005.00239.x · Cited by 384 · see citing works

The molecular structure of the Toll-like receptor 3 ligand-binding domain

Bell, J. K., Botos, I., Hall, P. R., Askins, J., Shiloach, J., Segal, D. M., & Davies, D. R. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0505077102 · Cited by 380 · see citing works

TLR signaling by tumor and immune cells: a double-edged sword

Huang, B., Zhao, J., Unkeless, J. C., Feng, Z., & Xiong, H. (2008) · Oncogene · doi:10.1038/sj.onc.1210904 · Cited by 377 · see citing works

RNA released from necrotic synovial fluid cells activates rheumatoid arthritis synovial fibroblasts via toll‐like receptor 3

Brentano, F., Schorr, O., Gay, R. E., Gay, S., & Kyburz, D. (2005) · Arthritis & Rheumatism · doi:10.1002/art.21273 · Cited by 377 · see citing works

Targeting cancer with mRNA–lipid nanoparticles: key considerations and future prospects

Kon, E., Ad‐El, N., Hazan‐Halevy, I., Stotsky‐Oterin, L., & Peer, D. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00811-9 · Cited by 385 · see citing works

Microglia: Agents of the CNS Pro-Inflammatory Response

Rodríguez-Gómez, J. A., Kavanagh, E., Engskog-Vlachos, P., Engskog, M. K. R., Herrera, A. J., Espinosa-Oliva, A. M., Joseph, B., Hajji, N., Venero, J. L., & Burguillos, M. A. (2020) · Cells · doi:10.3390/cells9071717 · Cited by 365 · see citing works

Toll‐like receptors in central nervous system glial inflammation and homeostasis

Kielian, T. (2006) · Journal of Neuroscience Research · doi:10.1002/jnr.20767 · Cited by 363 · see citing works

Activation of the mammalian immune system by siRNAs

Marques, J. T., & Williams, B. R. G. (2005) · Nature Biotechnology · doi:10.1038/nbt1161 · Cited by 357 · see citing works

Nucleoside modifications in RNA limit activation of 2'-5'-oligoadenylate synthetase and increase resistance to cleavage by RNase L

Anderson, B. R., Muramatsu, H., Jha, B. K., Silverman, R. H., Weissman, D., & Kariko, K. (2011) · Nucleic Acids Research · doi:10.1093/nar/gkr586 · Cited by 356 · see citing works

A comprehensive map of the toll‐like receptor signaling network

Oda, K., & Kitano, H. (2006) · Molecular Systems Biology · doi:10.1038/msb4100057 · Cited by 354 · see citing works

NKG2D function protects the host from tumor initiation

Smyth, M. J., Swann, J. B., Cretney, E., Zerafa, N., Yokoyama, W. M., & Hayakawa, Y. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20050994 · Cited by 344 · see citing works

Three decades of messenger RNA vaccine development

Verbeke, R., Lentacker, I., De Smedt, S. C., & Dewitte, H. (2019) · Nano Today · doi:10.1016/j.nantod.2019.100766 · Cited by 342 · see citing works

Toll‐like receptor (TLR) expression and TLR‐mediated cytokine/chemokine production by human uterine epithelial cells

Schaefer, T. M., Desouza, K., Fahey, J. V., Beagley, K. W., & Wira, C. R. (2004) · Immunology · doi:10.1111/j.1365-2567.2004.01898.x · Cited by 341 · see citing works

Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3

Vercammen, E., Staal, J., & Beyaert, R. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-07 · Cited by 322 · see citing works

Cancer Cells Expressing Toll-like Receptors and the Tumor Microenvironment

Sato, Y., Goto, Y., Narita, N., & Hoon, D. S. �. (2009) · Cancer Microenvironment · doi:10.1007/s12307-009-0022-y · Cited by 317 · see citing works

Clearance of apoptotic and necrotic cells and its immunological consequences

Krysko, D. V., D’Herde, K., & Vandenabeele, P. (2006) · Apoptosis · doi:10.1007/s10495-006-9527-8 · Cited by 316 · see citing works

A Critical Role of Toll-like Receptor 2 in Nerve Injury-induced Spinal Cord Glial Cell Activation and Pain Hypersensitivity

Kim, D., Kim, M. A., Cho, I., Kim, M. S., Lee, S., Jo, E., Choi, S., Park, K., Kim, J. S., Akira, S., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m607277200 · Cited by 315 · see citing works

Intranodal Vaccination with Naked Antigen-Encoding RNA Elicits Potent Prophylactic and Therapeutic Antitumoral Immunity

Kreiter, S., Selmi, A., Diken, M., Koslowski, M., Britten, C. M., Huber, C., Türeci, Ö., & Sahin, U. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-0699 · Cited by 309 · see citing works

EMERGING PARADIGM

Mollen, K. P., Anand, R., Tsung, A., Prince, J. M., Levy, R. M., & Billiar, T. R. (2006) · Shock · doi:10.1097/01.shk.0000228797.41044.08 · Cited by 306 · see citing works

Emerging role of Toll-like receptors in the control of pain and itch

Liu, T., Gao, Y., & Ji, R. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1219-5 · Cited by 302 · see citing works

The Multirole of Liposomes in Therapy and Prevention of Infectious Diseases

Nisini, R., Poerio, N., Mariotti, S., Santis, F. D., & Fraziano, M. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00155 · Cited by 299 · see citing works

Toll‐like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators

Bsibsi, M., Persoon-Deen, C., Verwer, R. W. H., Meeuwsen, S., Ravid, R., & van Noort, J. M. (2006) · Glia · doi:10.1002/glia.20328 · Cited by 296 · see citing works

DAMPs as mediators of sterile inflammation in aging-related pathologies

Feldman, N., Rotter-Maskowitz, A., & Okun, E. (2015) · Ageing Research Reviews · doi:10.1016/j.arr.2015.01.003 · Cited by 283 · see citing works

Role of astroglial toll-like receptors (TLRs) in central nervous system infections, injury and neurodegenerative diseases

Li, L., Acioglu, C., Heary, R. F., & Elkabes, S. (2021) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2020.10.007 · Cited by 283 · see citing works

Increased erythropoiesis in mice injected with submicrogram quantities of pseudouridine-containing mRNA encoding erythropoietin

Karikó, K., Muramatsu, H., Keller, J. M., & Weissman, D. (2012) · Molecular Therapy · doi:10.1038/mt.2012.7 · Cited by 282 · see citing works

Identification of Small Heat Shock Protein B8 (HSP22) as a Novel TLR4 Ligand and Potential Involvement in the Pathogenesis of Rheumatoid Arthritis

Roelofs, M. F., Boelens, W. C., Joosten, L. A. B., Abdollahi‐Roodsaz, S., Geurts, J., Wunderink, L. U., Schreurs, B. W., van den Berg, W. B., & Radstake, T. R. D. J. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.11.7021 · Cited by 278 · see citing works

Innate Immune Recognition in Infectious and Noninfectious Diseases of the Lung

Opitz, B., van Laak, V., Eitel, J., & Suttorp, N. (2010) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200909-1427so · Cited by 274 · see citing works

The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines

Morais, P., Adachi, H., & Yu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.789427 · Cited by 274 · see citing works

Lipid Nanoparticle-Delivered Chemically Modified mRNA Restores Chloride Secretion in Cystic Fibrosis

Robinson, E., MacDonald, K. D., Slaughter, K., McKinney, M., Patel, S., Sun, C., & Sahay, G. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.05.014 · Cited by 272 · see citing works

Differential Role for TLR3 in Respiratory Syncytial Virus-Induced Chemokine Expression

Rudd, B. D., Burstein, E., Duckett, C. S., Li, X., & Lukacs, N. W. (2005) · Journal of Virology · doi:10.1128/jvi.79.6.3350-3357.2005 · Cited by 271 · see citing works

Principles for designing an optimal mRNA lipid nanoparticle vaccine

Kon, E., Elia, U., & Peer, D. (2022) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2021.09.016 · Cited by 269 · see citing works

Innate Immunity in the Human Female Reproductive Tract: Antiviral Response of Uterine Epithelial Cells to the TLR3 Agonist Poly(I:C)

Schaefer, T. M., Fahey, J. V., Wright, J. A., & Wira, C. R. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.174.2.992 · Cited by 265 · see citing works

Challenges in developing personalized neoantigen cancer vaccines

Katsikis, P. D., Ishii, K. J., & Schliehe, C. (2023) · Nature reviews. Immunology · doi:10.1038/s41577-023-00937-y · Cited by 265 · see citing works

Inhibition of Toll-like Receptor and Cytokine Signaling—A Unifying Theme in Ischemic Tolerance

Karikó, K., Weissman, D., & Welsh, F. A. (2004) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000145666.68576.71 · Cited by 260 · see citing works

Recognition of Double-stranded RNA by Human Toll-like Receptor 3 and Downstream Receptor Signaling Requires Multimerization and an Acidic pH

de BOUTEILLER, O., Merck, E., Hasan, U. A., Hubac, S., Benguigui, B., Trinchieri, G., Bates, E. E. M., & Caux, C. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m507163200 · Cited by 260 · see citing works

Transcriptional signaling by double-stranded RNA: role of TLR3

Sen, G. C., & Sarkar, S. N. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.006 · Cited by 258 · see citing works

Preferential expression and function of Toll-like receptor 3 in human astrocytes

Farina, C., Krumbholz, M., Giese, T., Hartmann, G., Aloisi, F., & Meinl, E. (2004) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2004.09.009 · Cited by 252 · see citing works

Characterization of Toll-like receptors in the female reproductive tract in humans

Fazeli, A., Bruce, C., & Anumba, D. O. C. (2005) · Human Reproduction · doi:10.1093/humrep/deh775 · Cited by 246 · see citing works

Recent Advances in Lipid Nanoparticles and Their Safety Concerns for mRNA Delivery

Wang, J., Ding, Y., Chong, K. C., Cui, M., Cao, Z., Tang, C., Tian, Z., Hu, Y., Zhao, Y., & Jiang, S. (2024) · Vaccines · doi:10.3390/vaccines12101148 · Cited by 246 · see citing works

Immunogenic cell death

Garg, A. D., Dudek-Perić, A. M., Romano, E., & Agostinis, P. (2015) · The International Journal of Developmental Biology · doi:10.1387/ijdb.150061pa · Cited by 244 · see citing works

Inflammation and immune surveillance in cancer

Chow, M. T., Möller, A., & Smyth, M. J. (2011) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2011.12.004 · Cited by 241 · see citing works

The role of Toll-like receptors in the host response to viruses

Bowie, A., & Haga, I. R. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2004.11.007 · Cited by 239 · see citing works

ROLE OF TOLL-LIKE RECEPTORS IN THE DEVELOPMENT OF SEPSIS

Tsujimoto, H., Ono, S., Efron, P. A., Scumpia, P. O., Moldawer, L. L., & Mochizuki, H. (2008) · Shock · doi:10.1097/shk.0b013e318157ee55 · Cited by 239 · see citing works

Toll-Like Receptor 3 Is a Potent Negative Regulator of Axonal Growth in Mammals

Cameron, J. S., Alexopoulou, L., Sloane, J. A., DiBernardo, A., Ma, Y., Kosaras, B., Flavell, R. A., Strittmatter, S. M., Volpe, J. J., Sidman, R. L., et al. (2007) · Journal of Neuroscience · doi:10.1523/jneurosci.4290-06.2007 · Cited by 235 · see citing works

mRNA as gene therapeutic: How to control protein expression

Tavernier, G., Andries, O., Demeester, J., Sanders, N. N., De Smedt, S. C., & Rejman, J. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.10.020 · Cited by 232 · see citing works

Strategies to reduce the risks of mRNA drug and vaccine toxicity

Bitounis, D., Jacquinet, E., Rogers, M. A., & Amiji, M. M. (2024) · Nature Reviews Drug Discovery · doi:10.1038/s41573-023-00859-3 · Cited by 237 · see citing works

Danger signalling during cancer cell death: origins, plasticity and regulation

Garg, A. D., Martin, S., Gołąb, J., & Agostinis, P. (2013) · Cell Death and Differentiation · doi:10.1038/cdd.2013.48 · Cited by 225 · see citing works

Toll-Like Receptor-3-Activated Human Mesenchymal Stromal Cells Significantly Prolong the Survival and Function of Neutrophils

Cassatella, M. A., Mosna, F., Micheletti, A., Lisi, V., Tamassia, N., Cont, C., Calzetti, F., Pelletier, M., Pizzolo, G., & Krampera, M. (2011) · Stem Cells · doi:10.1002/stem.651 · Cited by 222 · see citing works

Mammalian Toll-like receptors: to immunity and beyond

Hopkins, P. A., & Sriskandan, S. (2005) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2005.02801.x · Cited by 220 · see citing works

mRNA Delivery for Therapeutic Anti-HER2 Antibody Expression In Vivo

Rybakova, Y., Kowalski, P. S., Huang, Y., Gonzalez, J. T., Heartlein, M. W., DeRosa, F., Delcassian, D., & Anderson, D. G. (2019) · Molecular Therapy · doi:10.1016/j.ymthe.2019.05.012 · Cited by 218 · see citing works

siRNA and isRNA: two edges of one sword

Schlee, M., Hornung, V., & Hartmann, G. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.06.001 · Cited by 215 · see citing works

Toll-Like Receptor Expression and Induction of Type I and Type III Interferons in Primary Airway Epithelial Cells

Ioannidis, I., Ye, F., McNally, B. A., Willette, M., & Flaño, E. (2013) · Journal of Virology · doi:10.1128/jvi.01956-12 · Cited by 216 · see citing works

Toll-like receptor stimulation in cancer: A pro- and anti-tumor double-edged sword

Dajon, M., Iribarren, K., & Cremer, I. (2016) · Immunobiology · doi:10.1016/j.imbio.2016.06.009 · Cited by 211 · see citing works

Preclinical Evaluation of TriMix and Antigen mRNA-Based Antitumor Therapy

Lint, S. V., Goyvaerts, C., Maenhout, S. K., Goethals, L., Disy, A., Benteyn, D., Pen, J. J., Bonehill, A., Heirman, C., Breckpot, K., et al. (2012) · Cancer Research · doi:10.1158/0008-5472.can-11-2957 · Cited by 210 · see citing works

Human endogenous RNAs: Implications for the immunomodulation of Toll-like receptor 3

Amarante, M. K., Oda, J. M. M., Reiche, E. M. V., Morimoto, H. K., Aoki, M. N., & Watanabe, M. A. E. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.303 · Cited by 7 · see citing works

Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3

Alexopoulou, L., Holt, A. C., Medzhitov, R., & Flavell, R. A. (2001) · Nature · doi:10.1038/35099560 · Cited by 6,129 · see citing works

Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses

Tatematsu, M., Seya, T., & Matsumoto, M. (2014) · Biochemical Journal · doi:10.1042/bj20131492 · Cited by 75 · see citing works

Transcriptional signaling by double-stranded RNA: role of TLR3

Sen, G. C., & Sarkar, S. N. (2005) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2005.01.006 · Cited by 258 · see citing works

Sensing of Viral Infection and Activation of Innate Immunity by Toll-Like Receptor 3

Vercammen, E., Staal, J., & Beyaert, R. (2008) · Clinical Microbiology Reviews · doi:10.1128/cmr.00022-07 · Cited by 322 · see citing works